Cytodyn Inc (CYDY)

[Borel Fields]

Whatever the BS games the stock people are playing, this drug has credibility as another example that immunomodulators, like leronlimab, are the solution. Hey, the FDA granted them a Phase III, just like they granted us.

I note, from clinicaltrials.gov, that their trial excludes those who are intubated prior to randomization, and the primary endpoint is either intubation or death by day 28.